Waisman Center partners on new multi-site NIH initiative to find Alzheimer’s biomarkers in Down syndrome

Brad Christian, PhD, Waisman investigator and associate professor of medical physics and psychiatry, is part of a new National Institutes of Health initiative to identify biomarkers and track the progression of Alzheimer’s in people with Down syndrome.

Discovery may halt progression of Alzheimer’s

In a finding that may cause a dramatic shift in the way scientists and researchers search for a therapy for Alzheimer’s disease, a team of researchers led by Jeff Johnson, an associate professor at the School of Pharmacy, has discovered that increased expression of a protein called transthyretin in the brain appears to halt the progression of the disease.